AZSTARYS
Attention Deficit Hyperactivity Disorder (ADHD)
Key Facts
About Corium
Corium, founded in 1997 and headquartered in Grand Rapids, USA, is a private, commercial-stage biopharmaceutical company with a core focus on neuroscience. The company has transitioned from its historical roots in drug delivery and generics to a specialized neuroscience player, currently marketing products like AZSTARYS for ADHD. Backed by investment firm B-Flexion, Corium is led by a seasoned executive team with extensive experience in pharmaceutical turnarounds, product launches, and business development, positioning it to grow within the competitive CNS market.
View full company profileAbout Collegium Pharmaceutical
Collegium Pharmaceutical is a publicly traded, commercial-stage biopharmaceutical company with a strategic focus on pain management and neuropsychiatry. The company has established itself through a disciplined strategy of portfolio diversification, specializing in abuse-deterrent formulations and the acquisition/commercialization of differentiated medicines. Under new leadership, Collegium is executing on a growth trajectory, aiming to strengthen its position in ADHD and expand its impact through a commitment to science, corporate responsibility, and robust commercial execution.
View full company profileTherapeutic Areas
Other Attention Deficit Hyperactivity Disorder (ADHD) Drugs
| Drug | Company | Phase |
|---|---|---|
| Adzenys XR-ODT® | Aytu BioScience | Approved |
| Cotempla XR-ODT® | Aytu BioScience | Approved |
| ADHD Portfolio (Other) | Aytu BioScience | Approved |